Xin W Wang

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Novel therapeutic strategies for targeting liver cancer stem cells
    Naoki Oishi
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 4258, USA
    Int J Biol Sci 7:517-35. 2011
  2. doi request reprint MicroRNAs in liver disease
    Xin Wei Wang
    Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Gastroenterology 142:1431-43. 2012
  3. pmc Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma
    Junfang Ji
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    Cell Biosci 1:4. 2011
  4. pmc Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?
    Mia Kumar
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA
    Cell Biosci 1:5. 2011
  5. pmc High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells
    Curtis J Henrich
    Molecular Targets Laboratory, National Cancer Institute, Frederick, MD, USA
    Chem Biol Drug Des 82:131-9. 2013
  6. pmc The clinical potential of microRNAs
    Anuradha Budhu
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    J Hematol Oncol 3:37. 2010

Collaborators

Detail Information

Publications6

  1. pmc Novel therapeutic strategies for targeting liver cancer stem cells
    Naoki Oishi
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 4258, USA
    Int J Biol Sci 7:517-35. 2011
    ..Here we provide a brief review of molecular signaling in liver CSCs and present insights into new therapeutic strategies for targeting liver CSCs...
  2. doi request reprint MicroRNAs in liver disease
    Xin Wei Wang
    Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Gastroenterology 142:1431-43. 2012
    ..We also discuss microRNAs as diagnostic and prognostic markers and microRNA-based therapeutic approaches for liver disease...
  3. pmc Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma
    Junfang Ji
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    Cell Biosci 1:4. 2011
    ..abstract:..
  4. pmc Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?
    Mia Kumar
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA
    Cell Biosci 1:5. 2011
    ....
  5. pmc High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells
    Curtis J Henrich
    Molecular Targets Laboratory, National Cancer Institute, Frederick, MD, USA
    Chem Biol Drug Des 82:131-9. 2013
    ..The identification of compounds with a variety of possible molecular targets suggests a likelihood of multiple mechanisms for modulation of EpCAM-dependent cell growth. ..
  6. pmc The clinical potential of microRNAs
    Anuradha Budhu
    Liver Carcinogenesis Section, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
    J Hematol Oncol 3:37. 2010
    ..Moreover, the potential application of microRNAs in clinical settings will also be highlighted. Finally, the challenges regarding the translation of research involving microRNAs to the clinical realm will be discussed...